Publication | Closed Access
Explicit Criteria for Determining Inappropriate Medication Use in Nursing Home Residents
1.2K
Citations
0
References
1991
Year
Family MedicinePrescription DrugsPharmacotherapyAdverse Drug ReactionClinical EpidemiologyClinical TrialsDrug MonitoringPain ManagementHome CareMedication ManagementHealth Services ResearchHealth SciencesDrug SafetyDrug InteractionsMedication UseGeriatricsExplicit CriteriaOutcomes ResearchInappropriate UseInappropriate Medication UseNursing Home ResidentsNursing Home PopulationSide EffectNursingPatient SafetyLong-term CareAnesthesiaMedicinePharmacoepidemiology
Inappropriate medication use in nursing homes is increasingly scrutinized, yet uniform, explicit criteria are lacking. A two‑round Delphi survey of 13 national experts produced consensus explicit criteria that rely mainly on pharmacy data for chart review or computerized analysis. The resulting 30 criteria cover common drug classes such as sedative‑hypnotics, antidepressants, antipsychotics, antihypertensives, NSAIDs, oral hypoglycemics, analgesics, dementia treatments, platelet inhibitors, H2 blockers, antibiotics, decongestants, iron, muscle relaxants, GI antispasmodics, and antiemetics, and can aid quality assurance, research, and guideline development. Arch Intern Med 1991;151:1825‑1832.
Increasing attention is being paid to inappropriate medication use in nursing homes. However, criteria defining the appropriate or inappropriate use of medication in this setting are not readily available and are not uniform. We used a two-round survey, based on Delphi methods, with 13 nationally recognized experts to reach consensus on explicit criteria defining the inappropriate use of medications in a nursing home population. The criteria were designed to use pharmacy data with minimal additional clinical data so that they could be applied to chart review or computerized data sets. The 30 factors agreed on by this method identify inappropriate use of such commonly used categories of medications as sedative-hypnotics, antidepressants, antipsychotics, antihypertensives, nonsteroidal anti-inflammatory agents, oral hypoglycemics, analgesics, dementia treatments, platelet inhibitors, histamine<sup>2</sup>blockers, antibiotics, decongestants, iron supplements, muscle relaxants, gastrointestinal antispasmodics, and antiemetics. These criteria may be useful for quality assurance review, health services research, and clinical practice guidelines. The method used to establish these criteria can be used to update and expand the guidelines in the future. (<i>Arch Intern Med</i>.1991;151:1825-1832)